AQUIPTA

Tablet, 60mg
RxActive license

Active substance (INN)

atogepant

Pharmaceutical form

Pharmaceutical formTablet
Strength60mg
PackagingUkupno 28 tableta u blisteru djeljivom na pojedinačne doze (4x(7x1)) u kartonskoj kutiji
ManufacturerAbbVie S.r.l., Italy
Therapeutic groupNervous system (N02CD07)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateJuly 29, 2025

Analogs in Montenegro

3

Other medicines with the same active substance

Source: CInMED register